The TIF International Conference has received approval from the National Drug Organization of Greece
(Εθνικό Οργανισμό Φαρμάκων)

TIF’s Educational Programme

The highly successful and internationally renowned Educational Programme of the Thalassaemia International Federation, constituting of the organisation of educational events, and the production, translation and distribution of publications, aims to spread knowledge on the treatment and prevention of thalassaemia, sickle cell disease, rare anaemias and other haemoglobin disorders.

14th International Conference on Thalassaemia and Other Haemoglobinopathies & 16th TIF Conference for Patients and Parents  (TIF International Conference)

TIF’s International Conference constitutes the biggest educational event in the field of haemoglobin disorders organised on a global scale, comprise of two parallel Conferences, namely the 14th International Conference on Thalassaemia and Other Haemoglobinopathies & 16th TIF Conference for Patients and Parents.

Together, these will attract over 2,000 participants, including health professionals, medical specialists, nurses, scientists, researchers, patients/parents, from over 60 countries around the world.

The Conference will take place on 17 – 19 November 2017 in Thessaloniki, Greece.

It is anticipated that the TIF International Conference will provide a unique forum for discussion covering the latest advances in research and overviews on prevention, management, other healthcare issues and current regional, European and international policies directly or indirectly relevant to haemoglobinopathies. Simultaneously, a special focus on patients’ disease education and capacity building programmes will facilitate the empowerment of the patient/parent community, whose strong and competent representation and participation is extremely important at all levels of decision-making bodies and processes leading to more productive and successful outcomes. It is well acknowledged that the input of knowledgeable and competent patient advocates has brought dramatic advances in the quality of health and life of patients across diseases all over the world, particularly those with chronic and rare diseases.

Furthermore, the networks of healthcare professionals which have developed globally in almost every region of the world, as result of research programmes, will be further strengthened by bringing medical specialists, patients/families and public health officials together to share knowledge and experiences. This effort will contribute to the reduction of inequalities in access to optimal care through the dissemination of good practice techniques and sharing of experiences of these preventable and treatable hereditary diseases.

Become a sponsor

There are a number of levels at which corporate companies can become involved in and sponsor this event – Silver, Gold and Platinum. In addition, other sponsorship opportunities are available (e.g. Exhibitor, Gala Dinner etc).

Click here to view the Sponsorship Packages available

These Packages represent general framework of support and we are always happy to talk to you about your particular requirements and to  put together a tailored support package.

The support and close collaboration of the industry is extremely valuable in achieving our goals and promoting a better quality of life for our patients in the region and around the world.

For more details contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.